The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population

被引:29
作者
Eskelinen, S
Suominen, P
Vahlberg, T
Löppönen, M
Isoaho, R
Kivelä, SL
Irjala, K
机构
[1] Turku Univ, Dept Family Med, Turku 20014, Finland
[2] Pori Hlth Ctr, Pori, Finland
[3] Mehilainen Oyj, Turku, Finland
[4] Univ Turku, Dept Biostat, SF-20500 Turku, Finland
[5] Harkatie Hlth Ctr, Lieto, Finland
[6] Turku Univ, Cent Hosp, Unit Family Med, Turku, Finland
[7] Satakunta Cent Hosp, Pori, Finland
[8] Turku Univ Hosp, FIN-20520 Turku, Finland
关键词
aged; hypothyroidism; reference interval; thyroid antibodies; thyroid function tests;
D O I
10.1515/CCLM.2005.236
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Our aims were: 1) to analyze the effect of the methodology used to derive clinically feasible cut-off values for thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb), which exhibit highly skewed distributions; and 2) to describe the influence of thyroid antibodies on thyroid stimulating hormone (TSH) and free thyroxine (FT4) reference intervals among thyroid disease-free aged subjects. The reference population consisted of 1086 individuals with a mean age of 73 years. The impacts of TPOAb and/or TgAb positivity on the reference intervals of TSH and FT4 were evaluated by both including and excluding subjects with elevated thyroid antibodies. The exclusion of subjects with elevated thyroid antibodies had no effect on the FT4 reference interval in either gender or on the TSH reference interval in men. Among women, the exclusion of 196 (34%) thyroid antibody-positive subjects resulted in lowering of the upper reference limit of TSH from 7.2 to 5.8 mIU/L. When the more stringent "mode-method'' by summing mode+(mode-2.5th percentile) was used, 334 women (58%) were excluded and the upper reference limit of TSH remained essentially identical. Regardless of the statistical methodology used to derive cut-off values, the effect of antibody positivity was found to be less than expected.
引用
收藏
页码:1380 / 1385
页数:6
相关论文
共 22 条
[11]   THE PREVALENCE AND PROGRESSION OF AUTOIMMUNE THYROID-DISEASE IN THE ELDERLY [J].
LAZARUS, JH ;
BURR, ML ;
MCGREGOR, AM ;
WEETMAN, AP ;
LUDGATE, M ;
WOODHEAD, JS ;
HALL, R .
ACTA ENDOCRINOLOGICA, 1984, 106 (02) :199-202
[12]   NECESSITY OF THE ASSESSMENT OF HEALTH-STATUS IN HUMAN IMMUNOGERONTOLOGICAL STUDIES - EVALUATION OF THE SENIEUR PROTOCOL [J].
LIGTHART, GJ ;
CORBERAND, JX ;
GEERTZEN, HGM ;
MEINDERS, AE ;
KNOOK, DL ;
HIJMANS, W .
MECHANISMS OF AGEING AND DEVELOPMENT, 1990, 55 (01) :89-105
[13]   Use of medications and polypharmacy are increasing among the elderly [J].
Linjakumpu, T ;
Hartikainen, S ;
Klaukka, T ;
Veijola, J ;
Kivelä, SL ;
Isoaho, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (08) :809-817
[14]   Undiagnosed diseases in patients with dementia -: A potential target group for intervention [J].
Löppönen, MK ;
Isoaho, RE ;
Räihä, IJ ;
Vahlberg, TJ ;
Loikase, SM ;
Takala, TI ;
Puolijoki, H ;
Irjala, KM ;
Kivelä, SL .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (3-4) :321-329
[15]  
*NAT AG MED SOC IN, CLASS MED ATC DEF DA
[16]   Hypothyroidism [J].
Roberts, CGP ;
Ladenson, PW .
LANCET, 2004, 363 (9411) :793-803
[17]   THE AGING THYROID - THYROID-DEFICIENCY IN THE FRAMINGHAM-STUDY [J].
SAWIN, CT ;
CASTELLI, WP ;
HERSHMAN, JM ;
MCNAMARA, P ;
BACHARACH, P .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (08) :1386-1388
[18]  
SUNDBECK G, 1995, CLIN CHEM, V41, P707
[19]   DRUG-THERAPY - DRUGS AND THYROID-FUNCTION [J].
SURKS, MI ;
SIEVERT, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1688-1694
[20]  
Taimela E, 1997, EUR J CLIN CHEM CLIN, V35, P889